SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 643.52 |
| Enterprise Value ($M) | 487.95 |
| Book Value ($M) | 214.91 |
| Book Value / Share | 3.44 |
| Price / Book | 2.99 |
| NCAV ($M) | 202.05 |
| NCAV / Share | 3.24 |
| Price / NCAV | 3.18 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.40 |
| Return on Assets (ROA) | -2.06 |
| Return on Equity (ROE) | -2.55 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.17 |
| Current Ratio | 6.17 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 244.04 |
| Assets | 256.90 |
| Liabilities | 41.99 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Immunome Aggregator, LP | |||
| 13G | Point72 Asset Management, L.P. | |||
| 13G/A | Vanguard Group Inc | |||
| 13G | T. Rowe Price Investment Management, Inc. | 9.60 | ||
| 13G | Janus Henderson Group Plc | 5.80 | ||
| 13G/A | Redmile Group, LLC | 8.10 | 26.04 | |
| 13G/A | Fmr Llc | 7.03 | 8.16 | |
| 13G | BlackRock, Inc. | 6.60 | 0.00 | |
| 13D/A | Barchas Isaac | 4.40 | -9.76 | |
| 13G/A | Alpine Global Management, LLC | 0.45 | -73.22 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 566,975 | 1,483,749 | 38.21 | |
| 199,378 | 728,394 | 27.37 | |
| 420,547 | 1,879,148 | 22.38 | |
| 1,022,980 | 4,110,683 | 24.89 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| IKT – Inhibikase Therapeutics, Inc. | IMCC – IM Cannabis Corp. |
| IMMX – Immix Biopharma, Inc. | IMNN – Imunon, Inc. |
| IMTX – Immatics N.V. |
Financial data and stock pages provided by
Fintel.io